TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention

NCT01613482 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Lack of enrollment

Conditions

Breast Cancer
Metastasis
Sur-expressing Her2-neu

Interventions

RADIATION: cerebral prophylactic radiation
DRUG: Trastuzumab
DRUG: Other chemotherapy in association with Trastuzumab

Sponsor

Centre Oscar Lambret